For systemic peptides like MOTS-c or SS-31 , the injection site matters less because the peptide enters systemic circulation regardless of where it is administered
Industry Funding: From the study, the funder was Eli Lilly and Company, which provided the study drug and was involved in study design, data collection, data analyses, data interpretation, and writing of the report
In the STEP 1 extension trial, most people regained a significant amount of weight within a year, though not everyone, and not the same amount
Retatrutide may push you to eat even less than this target, so focus on hitting your floor rather than maximizing the deficit
Can I speed up the titration to get results faster
The Compounded GLP-1 Regulatory Window in June 2026: What Every Buyer Should Understand Before Enrolling If you're reading this in June 2026 and seriously considering any compounded GLP-1 program - including LIV Body's - there is genuine regulatory context you deserve to have before you make a decision
